FRC
FRC Logo
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use FRC

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Commodities

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Research
Get Access
Sign In
Company ProfileRocket Doctor AI Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
AIDR.CN
Rocket Doctor AI Inc. Stock AnalysisComprehensive stock analysis for Rocket Doctor AI Inc. (AIDR.CN) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisAIDR.CN
AIDR.CN
Rocket Doctor AI Inc.
  • Company Overview
  • FRC Research
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
AIDR.CN
Home🔹Stocks🔹Rocket Doctor AI Inc.

Rocket Doctor AI Inc.

FRC Coverage
🇨🇦AIDR.CN•CNQ

Rocket Doctor AI Inc.

FRC Coverage
🇨🇦AIDR.CN•CNQ
Sentiment

Your view on AIDR.CN

Sentiment
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

*Rocket Doctor AI Inc. has paid FRC a fee for research coverage and distribution of reports.

About Rocket Doctor AI Inc.

Industry
Medical - Healthcare Information Services
Sector
Healthcare
CEO
Essam Hamza
Headquarters
800 – 885 West Georgia Street, Vancouver, BC, CA
Industry
Medical - Healthcare Information Services
Sector
Healthcare
CEO
Essam Hamza
Headquarters
800 – 885 West Georgia Street, Vancouver, BC, CA
Description

Rocket Doctor AI Inc. provides personalized health care information services in Canada. The company develops a mobile application for symptom assessment of users to address their health concerns, problems, and ongoing wellness management. It also offers a digital health app, an assessment tool which provides insights about health.

In addition, the company provides medical education, medical clinic, and clinical advisor solutions; and offers healthcare information resource.

FRC Research
Buy
Fair Value Estimate
CAD$1.26

U.S. Virtual Care Expansion Takes Off; Higher Costs Temper Outlook

Report · Sep 10, 2026

Sign in to view

FRC Research
Buy
Fair Value Estimate
CAD$1.26

U.S. Virtual Care Expansion Takes Off; Higher Costs Temper Outlook

Report · Sep 10, 2026

Sign in to view

FRC Research

Research Reports

FRC analyst coverage and recommendations.

Analyst Notes

Ongoing commentary and updates from FRC analysts.

Media

Infographics, videos, and posts covering the company.

Financial Data

Stock Data

Price chart, volume, and trading data.

Fair Value

What FRC thinks it is worth vs. the current price.

FRC's fair value estimate for Rocket Doctor AI Inc., and the rating behind it. AIDR.CN last traded at C$0.73; the estimate is read against that market price. FRC analysts run the firm's valuation model across the companies on this platform to estimate what each one is worth, rather than republishing a consensus average. Shows the current estimate, our rating, and when it was last revised. A free account covers 7 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

Valuation, profitability, liquidity and leverage ratios for Rocket Doctor AI Inc.. Starting points for Rocket Doctor AI Inc.: EPS -C$0.23, beta -0.19 — an Medical - Healthcare Information Services name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

Dividend history, yield and payout sustainability for Rocket Doctor AI Inc.. Rocket Doctor AI Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

Reported vs. expected earnings history for Rocket Doctor AI Inc.. Trailing twelve-month EPS for Rocket Doctor AI Inc. stands at -C$0.23. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

Income statement, balance sheet and cash flow history for Rocket Doctor AI Inc.. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Rocket Doctor AI Inc. valued side by side against its closest peers. Rocket Doctor AI Inc. is measured against Medical - Healthcare Information Services peers within the Healthcare sector. Peer-relative multiples and operating metrics, so the valuation is read in the context of its own sector rather than in isolation.

Ownership & News

Institutional Ownership

Premium

Which funds and firms own the stock.

Which institutions hold Rocket Doctor AI Inc., and how their positions are changing. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings. Included with FRC Premium.

Insider Trading

Premium

Recent buying and selling by company executives.

Buying and selling by Rocket Doctor AI Inc. executives and directors. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned. Included with FRC Premium.

Senate Trading

Premium

U.S. Senator disclosures filed under the STOCK Act.

U.S. Senate disclosures naming Rocket Doctor AI Inc.. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely. Included with FRC Premium.

House Trading

Premium

U.S. Representative disclosures filed under the STOCK Act.

U.S. House of Representatives disclosures naming Rocket Doctor AI Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals. Included with FRC Premium.

News

Latest headlines and market coverage.

Latest headlines and company announcements for Rocket Doctor AI Inc.. Coverage tracks Rocket Doctor AI Inc. within Medical - Healthcare Information Services (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

Peer companies

  • ADK.VDIAGNOS Inc.
  • AIML.CNAI/ML Innovations Inc.
  • UDOC.CNUnidoc Health Corp.
  • VHI.TOVitalhub Corp.

More Medical - Healthcare Information Services companies

  • AHE.AXAdheris Health Limited
  • AHGIFAlternate Health Corp.
  • AIMLFAI/ML Innovations Inc.
  • AIRDFRocket Doctor AI Inc.
  • ALBBYAlibaba Health Information Technology Limited
  • ALBHFAlibaba Health Information Technology Limited
  • ALC.AXAlcidion Group Limited
  • AMWLAmerican Well Corporation
  • APYIAspyra Inc.
  • AYA.AXArtrya Limited

Research Reports

4 reports

*Rocket Doctor AI Inc. has paid FRC a fee for research coverage and distribution of reports.

Sep 10, 2026

U.S. Virtual Care Expansion Takes Off; Higher Costs Temper Outlook

Rocket Doctor AI

Thumbnail for U.S. Virtual Care Expansion Takes Off; Higher Costs Temper Outlook
Jun 12, 2026

U.S. Expansion Accelerates Despite Earnings Headwinds

Rocket Doctor AI Inc. saw U.S. visits surge 160% in April, despite higher operating expenses impacting adjusted EBITDA.

Thumbnail for U.S. Expansion Accelerates Despite Earnings Headwinds
May 5, 2026

Scaling Virtual Care: Revenue Beat, Accelerating U.S. Expansion

Rocket Doctor AI Inc. raised $6.44M post-year-end, with a focus on U.S. expansion and a significant valuation discount compared to peers.

Thumbnail for Scaling Virtual Care: Revenue Beat, Accelerating U.S. Expansion
    1
  • 1
  • 2
8 notes

*Rocket Doctor AI Inc. has paid FRC a fee for research coverage and distribution of reports.

Oct 19, 2026· 1 week agoLatest

Company announcement

Reports Strong Q3 Patient Growth, Expects Record Revenue

FRC Analyst's Comment

AIDR operates an AI-powered digital health platform connecting physicians and patients through virtual care. The company reported strong patient growth in Q3-2026, completing 53,348 visits across Canada and the U.S., up from ~50,000 in Q2. U.S. visits increased 56% QoQ to 6,101, compared with negligible activity in Q3-2025, while Canadian visits rose 24% YoY to 47,247, up from ~46,000 in Q2. AIDR expects record quarterly revenue, building on Q2 revenue growth of 43% YoY to $0.73M.

We are encouraged by the continued growth as AIDR executes on its U.S. expansion strategy. Q3 financial results are expected next month, when we plan to publish a detailed update report. As noted in our last update, we estimate AIDR will need to raise additional capital in the near term. These positive operating metrics will be critical to supporting the company's fundraising efforts.

Sep 14, 2026· 1 month ago

Company announcement

Expands U.S. Operations with Strong Q3 Momentum

FRC Analyst's Comment

RD reported strong U.S. operating momentum in the first two months of Q3, with 3,625 patient visits, equivalent to 93% of total Q2 visits. Clinical hours reached 1,555, or 78% of Q2 levels.

RD operates an AI-powered digital health platform connecting physicians and patients through virtual care. We anticipate material sequential revenue growth in Q3, following Q2 revenue growth of 43% YoY. U.S. visits reached 3,911 in Q2, up 197% QoQ, while coverage expanded from ~21M to ~24M lives. We view continued U.S. growth as a key driver of RD’s revenue growth.

RD trades at a 56% discount to peers on forward revenue (1.0x vs. 2.3x), and a 54% discount on forward EBITDA (8.7x vs. 18.9x).

Aug 4, 2026· 2 months ago

Company announcement

Announces Convertible Debenture Financing

FRC Analyst's Comment

AIDR announced a non-brokered private placement of up to $2M through 12% unsecured convertible debentures to fund working capital, and support its U.S. expansion strategy. In our Q1-2026 report, we estimated the company would require approximately $2.5M in additional working capital, making this financing consistent with our expectations. We believe the remaining funding requirement could be met through the exercise of in-the-money options.

    1
  • 1
  • 2
  • 3

News

Latest Market News

No comments yet

Be the first to ask a question or say what you make of Rocket Doctor AI Inc.